HomeKALV • NASDAQ
add
Kalvista Pharmaceuticals Inc
Previous close
$15.79
Day range
$15.59 - $16.11
Year range
$7.30 - $16.32
Market cap
795.76M USD
Avg Volume
1.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 105.89M | 5.82% |
Net income | -52.23M | -16.97% |
Net profit margin | — | — |
Earnings per share | -0.99 | 7.48% |
EBITDA | -54.77M | -13.54% |
Effective tax rate | 1.61% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 220.62M | 4.86% |
Total assets | 250.77M | 6.53% |
Total liabilities | 155.38M | 439.10% |
Total equity | 95.39M | — |
Shares outstanding | 49.95M | — |
Price to book | 8.22 | — |
Return on assets | -52.23% | — |
Return on capital | -108.92% | — |
Cash Flow
Net change in cash
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -52.23M | -16.97% |
Cash from operations | -40.36M | -167.22% |
Cash from investing | -3.33M | 97.36% |
Cash from financing | 4.66M | -96.90% |
Net change in cash | -35.67M | -508.44% |
Free cash flow | -20.74M | -3,079.63% |
About
Founded
2004
Website
Employees
270
